Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price dropped 3.8% on Monday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The firm’s 50 day moving average is C$0.26 and its 200-day moving average is C$0.26. The stock has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Read More
- Five stocks we like better than Emerald Health Therapeutics
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Healthcare Pathbreakers With Long-Term Tailwinds
- There Are Different Types of Stock To Invest In
- 3 Tariff-Proof Retailers Making New All-time Highs
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- With Shares Near Highs, Here’s to Watch in Broadcom’s Q3 Report
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
